Life ScienceCompany
Kala Pharmaceuticals M&A Summary
Kala Pharmaceuticals has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.
Kala Pharmaceuticals’ largest acquisition to date was in 2021, when it acquired Combangio for $16M. It’s largest disclosed sale occurred in 2022, when it sold Kala Pharmaceuticals - EYSUVIS & INVELTYS to Alcon for $60M. Kala Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Kala Pharmaceuticals Business Overview
Where is Kala Pharmaceuticals headquartered?
Kala Pharmaceuticals is headquartered in Arlington, Massachusetts.
What is Kala Pharmaceuticals’ revenue?
Kala Pharmaceuticals disclosed revenue of 11M USD for 2021 and 6M USD for 2020.
What sector is Kala Pharmaceuticals in?
Kala Pharmaceuticals is a life science company.
When was Kala Pharmaceuticals founded?
Kala Pharmaceuticals was founded in 2009.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1